Your browser doesn't support javascript.
loading
Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis.
Yu, LaYow C; Dang, Danielle D; Zhuang, Sophie; Chen, Shuran; Zhuang, Zhengping; Rosenblum, Jared S.
Affiliation
  • Yu LC; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
  • Dang DD; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
  • Zhuang S; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
  • Chen S; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
  • Zhuang Z; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
  • Rosenblum JS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
Cancer Pathog Ther ; 1(2): 111-115, 2023 Apr.
Article in En | MEDLINE | ID: mdl-37750087
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Pathog Ther Year: 2023 Document type: Article Affiliation country: United States Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Pathog Ther Year: 2023 Document type: Article Affiliation country: United States Country of publication: Netherlands